What's new

Human medicines European public assessment report (EPAR): Accofil, filgrastim, Date of authorisation: 17/09/2014, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Accofil, filgrastim, Date of authorisation: 17/09/2014, Revision: 18, Status: Authorised

May 16, 2025 - 14:18
 0
Human medicines European public assessment report (EPAR): Accofil, filgrastim, Date of authorisation: 17/09/2014, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Accofil, filgrastim, Date of authorisation: 17/09/2014, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

FDA eyes additional Covid vaccine trials, as WHO suggests no update to Covid shot

Next Article

Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept...

Related Posts

Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 8, 2025  0

Veterinary medicines European public assessment report (EPAR): Fluralaner Intervet, fluralaner, Status: Opinion

Veterinary medicines European public assessment report ...

May 16, 2025  0

Human medicines European public assessment report (EPAR): Pomalidomide Zentiva, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0